Search

Heron Therapeutics Inc

Suletud

SektorTervishoid

0.33 3.13

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

0.31

Max

0.33

Põhinäitajad

By Trading Economics

Sissetulek

2.6M

-5.5M

Müük

3M

38M

Aktsiakasum

-0.03

Kasumimarginaal

-14.573

Töötajad

128

EBITDA

2.1M

-5.5M

Dividendid

By Acuity

Järgmine tulemuste avaldamine

3. nov 2026

Turustatistika

By TradingEconomics

Turukapital

-36M

60M

Eelmine avamishind

-2.8

Eelmine sulgemishind

0.33

Uudiste sentiment

By Acuity

58%

42%

279 / 339 Pingereas Healthcare

Heron Therapeutics Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

3. sept 2026, 23:56 UTC

News

Missouri American Water acquired Neosho's water systems for $34.5 million, adding 5,400 customers. Shares of American Water Works traded higher in after-market hours.

3. sept 2026, 23:56 UTC

News
Correlated Moves

Paychex receives a buy rating on strong revenue growth and strategic AI integration. After-market trading has shown little change since Thursday's close.

3. sept 2026, 23:56 UTC

News

Jefferies initiated coverage on Nexgen Energy with a Buy rating and a C$21 price target. Shares moved higher in after-market hours.

3. sept 2026, 23:51 UTC

News

Regeneron Pharmaceuticals faces a class action lawsuit over misleading statements about its Phase III Fianlimab-Libtayo Study, with shares trading lower in after-market hours.

3. sept 2026, 23:51 UTC

News
Social Media

Dutch Bros Inc filed a mixed securities shelf registration, enabling potential issuance of various securities. Shares are trading higher in after-market hours.

3. sept 2026, 23:51 UTC

News
Social Media

Tesla Inc. shares are lower in after-market trading following the invite-only launch event for its Cybercab in Austin, as details remain restricted.

3. sept 2026, 23:46 UTC

News

Weyerhaeuser Co remains about 4.95% below its 20-day moving average. Shares were roughly flat in after-market hours following a price target cut to $28.

3. sept 2026, 23:46 UTC

News
Social Media

Hewlett Packard Enterprise shares are lower in after-market trading, despite strong networking revenue guidance and broader market gains ahead of employment data.

3. sept 2026, 23:41 UTC

News

JP Morgan upgrades CPRT to Overweight, raises target to $40 after-market.

3. sept 2026, 23:41 UTC

News

Johnson & Johnson's shares are lower in after-market trading following FDA approval of IMAAVY and a jury verdict in a talc case.

3. sept 2026, 23:36 UTC

News

Ulta Beauty will participate in a Fireside Chat at the Barclays Global Consumer Conference on September 10, 2026. Shares are higher in after-market trading.

3. sept 2026, 23:31 UTC

News

Honeywell International Inc shares are lower in after-hours trading, despite broader market gains. The stock is near the lower end of its one-month range.

3. sept 2026, 23:26 UTC

News

Jefferies maintained a Buy rating on Five Below and raised its price target to $420. Shares are trading higher in after-market hours following the updates.

3. sept 2026, 23:21 UTC

News
Social Media

Meta Platforms Inc. shares are higher in after-market hours, supported by a Buy rating from Bank of America with a price target of $810.

3. sept 2026, 23:21 UTC

News

Thermo Fisher Scientific shares are lower in after-market hours despite CLSA initiating coverage with an Outperform rating and a $748 price target.

3. sept 2026, 23:11 UTC

News

Ethereum is trading higher during Thursday's session, remaining above its 20-day moving average and near the upper end of its one-month range.

3. sept 2026, 23:11 UTC

News

Ethereum is trading higher today, remaining above its 20-day moving average and near the upper end of its one-month trading range.

3. sept 2026, 23:05 UTC

News

USD/HKD trades roughly flat amid stable market activity. An increase in USDE supply to $4.26 billion may influence dynamics but has not impacted prices today.

3. sept 2026, 23:05 UTC

News

WEX Inc. shares decline in after-market hours despite announcing an integration with Driivz Ltd. for electric vehicle charging solutions, with a fair value of $187.30.

3. sept 2026, 23:05 UTC

Correlated Moves
News

Elastic NV plans to integrate OpenAI GPT cyber models into its Elastic Security platform, enhancing security capabilities. Shares are trading roughly flat in after-market hours.

3. sept 2026, 23:05 UTC

Macro Event
Correlated Moves
News

The USD/PLN exchange rate is declining amid mixed U.S. jobless claims data, with initial claims rising slightly above expectations.

3. sept 2026, 23:02 UTC

News
Social Media

Lululemon Athletica reported second-quarter revenue of $2.42 billion, below estimates. The stock fell sharply in after-market hours, reaching its lowest level since May 2018.

3. sept 2026, 23:02 UTC

News
Correlated Moves
Social Media

DocuSign shares rise in after-market trading following strong fiscal Q2 results and raised revenue guidance, despite earlier pulling back from a session high.

3. sept 2026, 23:01 UTC

News

PulteGroup Inc shares are higher in after-market hours following a Buy rating from StoneX analyst Michael, who set a price target of $148.00.

3. sept 2026, 23:01 UTC

News

eGain Corp shares are lower in after-market trading following disappointing fiscal 2027 guidance, despite reporting revenue and adjusted EPS that exceeded estimates.

3. sept 2026, 23:01 UTC

News

Concrete Pumping Holdings reported strong Q3 results, raising revenue guidance and announcing a quarterly dividend, driving shares higher in after-market trading.

3. sept 2026, 23:01 UTC

News
Social Media
Event

UiPath Inc shares declined in after-market hours despite reporting second-quarter revenue of $410 million and raising its fiscal year 2027 outlook.

3. sept 2026, 23:01 UTC

News
Event

Oxford Industries reports second-quarter sales of $394 million and lowers full-year adjusted EPS guidance to $1.60-$2.00, leading shares lower in after-market hours.

3. sept 2026, 23:01 UTC

News
Social Media

Strategy Inc shares declined after hours, retracing from earlier gains amid social media discussions and news from Iran affecting sentiment.

3. sept 2026, 23:01 UTC

News
Event
Social Media

Smith & Wesson Brands reported strong Q1 results, with net sales of $112.6 million and adjusted EPS of $0.06, boosting shares in after-market trading.

Võrdlus sarnastega

Hinnamuutus

Heron Therapeutics Inc Prognoos

Hinnangu Konsensus

By TipRanks

Neutraalne

2 ratings

0

Osta

2

Hoia

0

Müü

Sentiment

By Acuity

279 / 339 Pingereas Tervishoid

Uudiste sentiment

Tõusu märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Üle keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Heron Therapeutics Inc

Heron Therapeutics, Inc., a commercial-stage biotechnology company, focuses on enhancing the lives of patients by developing and commercializing therapeutic that enhances medical care. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emetogenic chemotherapy, or anthracycline and cyclophosphamide combination chemotherapy regimens; and CINVANTI, an intravenous formulation of aprepitant, a substance P/neurokinin-1 receptor antagonist for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cancer chemotherapy, as well as nausea and vomiting associated with moderately emetogenic cancer chemotherapy. The company is also developing ZYNRELEF, a dual-acting local anesthetic that delivers a fixed-dose combination of the local anesthetic bupivacaine and a low dose of the nonsteroidal anti-inflammatory drug meloxicam; and APONVIE, an intravenous formulation of a substance P/neurokinin-1 receptor antagonist indicated for the prevention of postoperative nausea and vomiting in adults. The company was formerly known as A.P. Pharma, Inc. and changed its name to Heron Therapeutics, Inc. in January 2014. Heron Therapeutics, Inc. was founded in 1983 and is headquartered in Cary, North Carolina.
help-icon Live chat